Immune Response BioPharma Announces REMUNE Granted Orphan Designation for Pediatric HIV/AIDS

February 18, 2014 Immune Response BioPharma, Inc. Today, Announces its Flagship HIV/AIDS Vaccine REMUNE Granted Orphan Designation for Pediatric HIV/AIDS diseases by the FDA. The FDA Office of Orphan Products Development (OOPD) mission is to advance the evaluation and development of products (drugs, biologics, devices, or medical foods) that demonstrate promise for the diagnosis and/or treatment of rare diseases or conditions. Orphan Drug …